Tham khảo Quadrosilan

  1. ↑ J. Elks (14 tháng 11 năm 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. tr. 629–. ISBN 978-1-4757-2085-3.
  2. ↑ I.K. Morton; Judith M. Hall (6 tháng 12 năm 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. tr. 243–. ISBN 978-94-011-4439-1.
  3. ↑ Alfthan, Olof; Andersson, Lennart; Luigi Esposti, Pier; Dorothea Fosså, Sophie; Arne Gammelgaard, Peter; Erik Gjöres, Jan; Isacson, Sune; Rasmussen, Finn; Ruutu, Mirja (1983). “Cisobitan® in Treatment of Prostatic Cancer”. Scandinavian Journal of Urology and Nephrology. 17 (1): 37–43. doi:10.3109/00365598309179778. ISSN 0036-5599.
  4. ↑ Chisholm, Geoffrey D. (1985). “Treatment of advanced cancer of the prostate”. Seminars in Surgical Oncology. 1 (1): 38–55. doi:10.1002/ssu.2980010106. ISSN 8756-0437.
  5. ↑ Yitzhak Apeloig (1989). The Chemistry of Organic Silicon Compounds. John Wiley & Sons Canada, Limited. tr. 1154. ISBN 978-0-471-91993-3.
  6. ↑ Mills, John S; Showell, Graham A (2004). “Exploitation of silicon medicinal chemistry in drug discovery”. Expert Opinion on Investigational Drugs. 13 (9): 1149–1157. doi:10.1517/13543784.13.9.1149. ISSN 1354-3784.
  7. ↑ Strindberg, Bengt (1978). “Biochemical Effects of 2, 6-cis-Diphenylhexamethylcyclotetrasiloxane in Man”: 515–520. doi:10.1007/978-1-4613-4018-8_23. Chú thích journal cần |journal= (trợ giúp)
  8. ↑ Krarup T, Rasmussen F, Gammelgaard PA (1978). “Prostatic carcinoma treated with 2,6-cis-diphenylhexamethylcyclotetrasiloxane (Cisobitan)”. Scand. J. Urol. Nephrol. 12 (1): 11–5. PMID 345431.